Healthcare · NIFTY 500

Fortis Healthcare Limited

NSEFORTIS BSE532843 ISININE061F01013 SeriesEQ Listed on NSE · BSE

₹760.00 -12.00 (-1.55%) Updated 12 Nov, 8:49 pm IST

Open chart Back to screener

Price, daily close-24.75% in a year

Today

Open: ₹772.00
Prev close: ₹772.00
Day high: ₹773.75
Day low: ₹755.25
Volume: 19.42 L
Value traded: ₹147.81 Cr
Upper circuit: ₹783.10
Lower circuit: ₹737.50
52W high: ₹1,034.50
52W low: ₹704.95
1 month: +0.51%
6 months: -21.27%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹57,377 Cr

P/E (TTM)55.23

P/B5.48

Book value / share₹138.79

EPS (TTM)₹13.76

ROE9.9%

Dividend yield0.13%

Dividend (12m)₹1.00 / share

Net margin (TTM)10.5%

Operating margin22.9%

Debt / equity0.30

Current ratio0.79

EV / EBITDA28.06

Sales growth (YoY qtr)+17.30%

Profit growth (YoY qtr)-2.96%

Sales CAGR 3Y+13.17%

Profit CAGR 3Y+20.95%

Shares75.50 Cr

Quarterly results

Results for each quarter

Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

1,680135

Dec 23

1,786179

Mar 24

1,859166

Jun 24

1,988176

Sep 24

1,928248

Dec 24

2,007184

Mar 25

2,167260

Jun 25

2,331322

Sep 25

2,265194

Dec 25

2,365266

Mar 26

2,545266

Jun 26

2,735312

Sep 26

Revenue · QoQ (vs last quarter)

—+6.3%+4.1%+7.0%-3.0%+4.1%+7.9%+7.6%-2.8%+4.4%+7.6%+7.5%

Revenue · YoY (vs a year ago)

————+15%+12%+17%+17%+17%+18%+17%+17%

Net profit · QoQ (vs last quarter)

—+33%-7.3%+6.1%+41%-26%+42%+24%-40%+37%+0.2%+17%

Net profit · YoY (vs a year ago)

————+84%+2.9%+57%+83%-22%+45%+2.3%-3.0%

RevenueNet profitLine = trend

1.78

Dec 23

2.37

Mar 24

2.20

Jun 24

2.34

Sep 24

3.28

Dec 24

2.44

Mar 25

3.45

Jun 25

4.26

Sep 25

2.57

Dec 25

3.52

Mar 26

3.53

Jun 26

4.14

Sep 26

EPS (₹) · YoY (vs a year ago)

————+84%+3.0%+57%+82%-22%+44%+2.3%-2.8%

EPS (₹)Line = trend

₹ Cr	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26	Sep 26
Revenue	1,680	1,786	1,859	1,988	1,928	2,007	2,167	2,331	2,265	2,365	2,545	2,735
Other income	6.8	9.8	13.0	13.2	20.9	19.8	15.4	22.6	8.3	4.4	14.5	6.7
Total income	1,686	1,796	1,872	2,002	1,949	2,027	2,182	2,354	2,273	2,369	2,560	2,742
Raw material	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Purchases	389	403	455	466	457	460	518	548	522	521	586	601
Employee cost	282	272	295	290	294	287	313	317	328	340	404	409
Other expenses	720	720	768	802	805	821	849	919	916	974	1,031	1,107
Total expenses	1,516	1,532	1,643	1,685	1,696	1,742	1,847	1,956	1,965	2,039	2,210	2,318
Operating profit	292	384	343	375	399	382	503	580	460	520	547	626
OPM %	17.4%	21.5%	18.4%	18.9%	20.7%	19.0%	23.2%	24.9%	20.3%	22.0%	21.5%	22.9%
Finance cost	33.0	34.7	35.3	36.4	45.2	67.6	69.6	74.9	85.7	84.3	80.4	78.3
Depreciation	86.9	92.2	91.0	95.1	97.3	102	101	106	120	122	122	128
Exceptional items	7.7	3.1	0.2	-59.8	23.8	-53.6	12.6	23.5	-45.9	-12.5	9.5	3.0
Profit before tax	179	267	229	257	277	232	348	422	262	318	359	426
Tax	48.9	68.2	56.1	68.0	25.1	48.5	83.8	96.6	68.3	53.0	90.4	112
Net profit	134	203	174	193	254	188	267	329	197	271	273	320
Profit to shareholders	135	179	166	176	248	184	260	322	194	266	266	312
EPS (₹)	1.78	2.37	2.20	2.34	3.28	2.44	3.45	4.26	2.57	3.52	3.53	4.14

Profit & loss

Results for each year

8 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

4,4692.8-224

FY19

4,632671136

FY20

4,030406-110

FY21

5,7181,384555

FY22

6,2981,175589

FY23

6,8931,284599

FY24

7,7831,499774

FY25

9,1282,0631,042

FY26

Revenue · YoY (vs a year ago)

—+3.6%-13%+42%+10%+9.5%+13%+17%

Net profit · YoY (vs a year ago)

—+161%-181%+606%+6.1%+1.7%+29%+35%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	4,469	4,632	4,030	5,718	6,298	6,893	7,783	9,128
Other income	92.4	52.6	46.6	27.3	61.7	38.3	66.9	50.7
Total expenses	4,814	4,520	4,082	5,096	5,641	6,099	6,765	7,807
Employee cost	914	916	849	973	1,047	1,120	1,167	1,297
Operating profit	2.8	671	406	1,384	1,175	1,284	1,499	2,063
OPM %	0.1%	14.5%	10.1%	24.2%	18.7%	18.6%	19.3%	22.6%
Finance cost	337	205	166	147	129	131	184	314
Depreciation	233	292	291	301	316	343	386	449
Profit before tax	-475	227	-4.3	964	792	848	996	1,350
Tax	114	148	99.5	198	181	213	198	302
Tax rate %	—	65.1%	—	20.5%	22.8%	25.1%	19.9%	22.4%
Net profit	-224	91.5	-56.2	790	633	645	809	1,064
Profit to shareholders	—	136	-110	555	589	599	774	1,042
Net margin %	-5.0%	2.9%	-2.7%	9.7%	9.3%	8.7%	9.9%	11.4%
EPS (₹)	-3.70	0.77	-1.45	7.35	7.80	7.93	10.26	13.80

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

7,242926141

Mar 23

7,663858235

Mar 24

8,9172,475140

Mar 25

9,8962,873407

Mar 26

10,4783,164150

Sep 26

Shareholders' equity · YoY (vs a year ago)

—+5.8%+16%+11%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 23	Mar 24	Mar 25	Mar 26	Sep 26
Shareholders' equity	7,242	7,663	8,917	9,896	10,478
Long-term borrowings	755	741	2,311	2,401	2,502
Short-term borrowings	171	117	164	471	662
Total borrowings	926	858	2,475	2,873	3,164
Current liabilities	1,314	3,170	1,607	2,121	2,397
Fixed assets (PPE)	4,850	5,268	5,848	5,348	7,020
Inventories	123	107	115	135	153
Trade receivables	582	628	784	1,044	1,323
Cash & equivalents	141	235	140	407	150
Current assets	1,832	2,192	2,165	1,819	1,904
Total assets	12,434	13,289	13,692	15,966	16,415
Debt / equity	0.13	0.11	0.28	0.29	0.30

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

865-514-517

FY22

822-374-471

FY23

1,100-886-86.5

FY24

1,424-779-714

FY25

1,602-1,538164

FY26

Operations · YoY (vs a year ago)

—-5.0%+34%+29%+12%

OperationsInvestingFinancingLine = trend

₹ Cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	865	822	1,100	1,424	1,602
Cash from investing	-514	-374	-886	-779	-1,538
Cash from financing	-517	-471	-86.5	-714	164
Spent on fixed assets	-215	-447	-942	-847	-946
Free cash flow	650	375	158	577	656
Net cash flow	-166	-22.7	127	-69.3	227

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

31.2%Dec 23

31.2%Mar 24

31.2%Jun 24

31.2%Sep 24

31.2%Dec 24

31.2%Mar 25

31.2%Jun 25

31.2%Sep 25

31.2%Dec 25

31.2%Mar 26

31.2%Jun 26

31.2%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

31.2%promoter

Promoter & group: 31.17%
Public (FIIs, mutual funds, retail…): 68.83%
Promoter change, last quarter: 0.00 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

Dividend - Re 1 Per ShareEx 24-Jul-2026
Dividend - Re 1 Per ShareEx 25-Jul-2025
Dividend - Re 1 Per ShareEx 24-Jul-2024
Dividend - Re 1 Per ShareEx 20-Jul-2023
Annual General MeetingEx 16-Sep-2016
Annual General MeetingEx 14-Sep-2015
Annual General MeetingEx 18-Sep-2014
Annual General MeetingEx 19-Sep-2013

Board meetings

the financial results for the period ended September 30, 2026 and other business matters05-Nov-2026
the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Alteration of form or nature or rights of securities…05-Nov-2026
FORTIS HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 06-Aug-2026 to inter-alia consider and approve the Unaudited Fi…06-Aug-2026
the Un-audited financial results (standalone & Consolidated) for the quarter ended Jun 30, 202606-Aug-2026
the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.22-May-2026

Filings with NSE

Analysts/Institutional Investor Meet/Con. Call Updates10 Nov
Analysts/Institutional Investor Meet/Con. Call Updates6 Nov
Copy of Newspaper Publication6 Nov
General Updates5 Nov
Investor Presentation5 Nov
Press Release5 Nov
Outcome of Board Meeting5 Nov

Latest news

Fortis Healthcare (NSEI:FORTIS) Stock Forecast & Analyst PredictionsSimply Wall St · 9 Nov, 1:30 pm Fortis Healthcare shares in focus after revenue, EBITDA rise in Q2 - A look at how its business segments fared - CNBC TV18LinkedIn · 6 Nov, 12:29 pm Jefferies is bullish on 6 healthcare stocks with upside potential of up to 46%. Own any?The Economic Times · 2 Oct, 12:30 pm Fortis Healthcare Shares Decline Over 2%; Stock Among Top Losers on Nifty Midcap 150Moneycontrol.com · 12 Aug, 12:30 pm Fortis Healthcare shares fall after SC allows forensic audit to go aheadCNBC TV18 · 28 Sep, 12:30 pm Hospital operators fall; Fortis Healthcare shares tank nearly 6 pc on WednesdayET HealthWorld · 13 Aug, 12:30 pm Fortis Healthcare Share Price Today: Price Action AnalysisUnivest · 28 Oct, 12:30 pm Fortis Healthcare Shares Rise 3% on Q1 Revenue GrowthEquitypandit · 7 Aug, 12:30 pm

About

About Fortis Healthcare Limited

Fortis Healthcare Limited is listed on the NSE under the symbol FORTIS and belongs to the Healthcare sector.

BRANDS

Agilus Diagnostics

Company details

Company name: Fortis Healthcare Limited
NSE symbol: FORTIS
BSE scrip code: 532843
ISIN: INE061F01013
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 9 May 2007
Face value: ₹10 per share
Market lot: 1 share
Shares issued: 75.50 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Hospital/Nursing Management
Managing director / CEO: Ashutosh Raghuvanshi
Chair: Leo Puri
Headquarters: Gurugram, Haryana, India
Registered address: Tower A, 3rd Floor, Unitech Business Park, South City-1, Gurugram, Haryana- 120001
Founded: 1996
Employees: 29,616
Financial year: April to March
Results basis: Consolidated
Website: fortishealthcare.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Fortis Healthcare Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers